RWE signs two 15-year Power Purchase Agreements with Microsoft to supply clean energy from two onshore wind projects in Texas with a combined capacity of 446 megawatts
May 23, 2024 10:13 ET
|
RWE
Austin, Texas, May 23, 2024 (GLOBE NEWSWIRE) -- RWE, one of the leading renewable energy companies in the U.S. and worldwide, has signed two 15-year Power Purchase Agreements (PPAs) with Microsoft...
RWE expands U.S. development portfolio with new project acquisitions across three states
May 20, 2024 11:11 ET
|
RWE
AUSTIN, May 20, 2024 (GLOBE NEWSWIRE) -- RWE Clean Energy continues to bolster its renewables development pipeline in the U.S., adding 599 megawatts (MW) of solar and energy storage projects...
Custom Research Presented at AMIA Informatics Summit Reveals Promising Findings for Healthcare Innovation
March 14, 2023 08:05 ET
|
Syapse
SAN FRANCISCO, March 14, 2023 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
Syneos Health Adds HUB Patient Suite to Deployment Solutions Business
October 27, 2022 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a dedicated...
Setareh Williams Joins Cobbs Creek Healthcare as Managing Partner/Head of Real-World Evidence and Scientific Communications
May 04, 2022 09:00 ET
|
Cobbs Creek Healthcare
Newtown Square PA, May 04, 2022 (GLOBE NEWSWIRE) -- Cobbs Creek Healthcare, a data science and advanced analytics firm transforming healthcare decision-making through innovative insights and a...
The real world evidence (RWE) market is projected to be worth USD 4.5 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis
March 03, 2021 08:45 ET
|
Roots Analysis
London, March 03, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of...
Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research
December 03, 2020 08:49 ET
|
Syneos Health, Inc.
BOSTON and MORRISVILLE, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization and ConcertAI, the leader in oncology...
Syapse Announces Research Collaboration with the FDA Focused on the Regulatory Use of Real-World Evidence
August 14, 2019 06:00 ET
|
Syapse
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement...